Masaki Otagiri

发表

Structural basis of the drug-binding specificity of human serum albumin.

S. Curry, I. Petitpas, M. Otagiri, 2005, Journal of molecular biology.

p-Cresyl sulfate, a uremic toxin, causes vascular endothelial and smooth muscle cell damages by inducing oxidative stress

Masafumi Fukagawa, Toru Maruyama, Kazutaka Matsushita, 2014, Pharmacology research & perspectives.

Improvement of dissolution and absorption characteristics of benzodiazepines by cyclodextrin complexation

F. Hirayama, K. Uekama, M. Otagiri, 1983 .

S-Nitrosated human serum albumin dimer is not only a novel anti-tumor drug but also a potentiator for anti-tumor drugs with augmented EPR effects.

Jun Fang, Hiroshi Maeda, Toru Maruyama, 2012, Bioconjugate chemistry.

A molecular functional study on the interactions of drugs with plasma proteins.

M. Otagiri, Masaki Otagiri, 2005, Drug metabolism and pharmacokinetics.

Controlled release of indomethacin by chitosan-polyelectrolyte complex: optimization and in vivo/in vitro evaluation

Teruko Imai, T. Imai, M. Otagiri, 1993 .

Practical aspects of the ligand-binding and enzymatic properties of human serum albumin.

M. Otagiri, Masaki Otagiri, Ulrich Kragh-Hansen, 2002, Biological & pharmaceutical bulletin.

[Study on binding of drug to serum protein].

M. Otagiri, Masaki Otagiri, 2009, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

3ircular dichroism simulation shows a site-II-to-site-I displacement of human serum albumin-bound diclofenac by ibuprofen

Toru Maruyama, Yasuhiro Tsutsumi, M. Otagiri, 2000, AAPS PharmSciTech.

Inclusi on complexations of steroid hormones with cyclodextrins in water and in solid phase

Masaki Yamasaki, F. Hirayama, K. Uekama, 1982 .

Crystallographic analysis of the ternary complex of octanoate and N-acetyl-l-methionine with human serum albumin reveals the mode of their stabilizing interactions.

Shuichi Miyamoto, S. Miyamoto, M. Otagiri, 2017, Biochimica et biophysica acta. Proteins and proteomics.

The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants.

Toru Maruyama, M. Otagiri, T. Maruyama, 2003, Biochimica et biophysica acta.

Albumin-drug interaction and its clinical implication.

Toru Maruyama, M. Otagiri, T. Maruyama, 2013, Biochimica et biophysica acta.

Pharmaceutical Strategies Utilizing Recombinant Human Serum Albumin

M. Otagiri, Masaki Otagiri, Ulrich Kragh-Hansen, 2002, Pharmaceutical Research.